What is FAP Kdpharma Group

  Familial Adenomatous Polyposis (FAP) is a hereditary condition that results in the early development of polyps and colorectal cancer that could starts at the early age of 12 years old. FAP is considered as an orphan disease, with a prevalence of 0,6/1,0 out of 10.000. Caused by germline mutations in the APC gene it is characterized by the development of hundreds to thousands of polyps and carriers of the APC gene mutation, if not treated appropriately, will develop colorectal cancer. Unfortunately at the moment there is no safe treatment available.

Familial Adenomatous Polyposis Drugs in Development by Stages

KD Pharma Group & SLA Pharma Initiate Clinical Trial For COVID-19

KD Pharma

News Kdpharma Group

Leader in Pharmaceutical Omega 3 Manufacturing

KD Pharma Group

Fatty acid and sweet wormwood on road to clinical trials for COVID-19

KD Pharma Group - Crunchbase Company Profile & Funding

KD Pharma Group

SLA Pharma

Justin Slagel on LinkedIn: BIO-Europe Spring 2023

Allergy Research Group DHEA 25mg Supplement - Hormone

KD Pharma Group - capiton

SLA Pharma AG & KD Pharma Group COVID-19 Clinical Trial Approved